课题基金 / 基金详情

Minority Stress and Cigarette Smoking among Sexual Minority Youth

Minority Stress and Cigarette Smoking among Sexual Minority Youth
性少数青少年的少数压力和吸烟
批准号:
9316310
负责人:
ROBERT MIRANDA
金额:
$25.5万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-06-23 至 2019-01-31

项目摘要

项目成果

ROBERT MIRANDA的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT Health disparities in tobacco and other substance use are well documented between sexual minorities (e.g., lesbian, gay, bisexual, or queer) and heterosexual individuals across the lifespan. In particular, sexual minority youth (SMY) initiate tobacco use at younger ages and smoke cigarettes at higher rates than their heterosexual counterparts. Stigma and discrimination-related stressors specific to their minority sexual orientation (i.e., minority stressors) contribute to our understanding of health disparities among SMY. Minority stressors are often experienced daily by SMY. As such, SMY may smoke cigarettes as a way to cope with negative affect elicited by these stigma-based stressors. In fact, cross-sectional research shows that minority stressors are correlated with cigarette smoking and other substance use among SMY. Important limitations of the extant literature, however, include overreliance on cross-sectional and retrospective self-report data, failure to account for within- and between-individual differences in minority stressors and smoking behaviors, and lack of discernment of unique contributions of minority stressors on smoking beyond individual differences in daily general stressors, lifetime cumulative stress, and mental health. In addition, we know very little about the mediating mechanisms between minority stressors and cigarette smoking. Consistent with Institute of Medicine and the NIH Sexual and Gender Minority Research Coordinating Committee's call to expand our understanding of factors contributing to SMY’s higher levels of tobacco and other substance use, and in response to NIH PA-15-263’s focus on sexual minority health research, we propose an innovative exploratory study (R21). We propose a rigorous examination of the effects of minority stressors on cigarette smoking in real time in the natural environment among SMY using electronic experience sampling methods, specifically ecological momentary assessment (EMA). Our primary aims are to examine: a) the relationship between minority stressors and proximal changes in smoking in real time in the natural environment among 60 SMY who are regular smokers using EMA over a 30-day period; b) the effects of minority stressors on proximal changes in affect and craving; and, c) the mediating effects of affect and craving on the relationship between minority stressors and cigarette smoking. Our secondary aims of this study are to examine the effects of minority stressors on proximal changes in other substance use as well as to test resilience resources and contextual risk factors that might be associated with smoking. Findings from this exploratory study would have important theoretical implications for minority stress theory and inform the development of culturally sensitive smoking prevention and cessation interventions for SMY, targeting specific within-individual mechanisms as well as contextual factors. The proposed R21 will also provide pilot data for large scale research to more rigorously test the fine-grained psychosocial resilience and risk mechanisms associated with SMY’s smoking.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
NIAAA Medications Development Clinical Investigations Network for the Treatment of Alcohol Use Disorder
  • 批准号:
    10591392
  • 项目类别:
  • 资助金额:
    $3.73万
  • 财政年份:
    2021
  • 负责人:
    ROBERT MIRANDA
  • 依托单位:
CORE FUNCTION ACTIVITIES TASK ORDER FOR ADVISORY SERVICES AND ADMINISTRATIVE REPORTING
  • 批准号:
    10953480
  • 项目类别:
  • 资助金额:
    $3.85万
  • 财政年份:
    2021
  • 负责人:
    ROBERT MIRANDA
  • 依托单位:
NIAAA Medications Development Clinical Investigations Network for the Treatment of Alcohol Use Disorder
  • 批准号:
    10506081
  • 项目类别:
  • 资助金额:
    $3.89万
  • 财政年份:
    2021
  • 负责人:
    ROBERT MIRANDA
  • 依托单位:
Proof-of-Concept Clinical Trial of Lamotrigine as a Candidate Pharmacotherapy for Adolescent Alcohol Use Disorder
  • 批准号:
    10192619
  • 项目类别:
  • 资助金额:
    $19.61万
  • 财政年份:
    2020
  • 负责人:
    ROBERT MIRANDA
  • 依托单位:
海外基金